Retatrutide for weight loss: Clinical trial evidence The phase 1 clinical trials of retatrutide involved 72 individuals with diagnosed type 2 diabetes
[1] [2] This medication works by mimicking the action of endogenous GLP-1, enhancing glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety through central nervous system pathways
Some people may also experience digestive side effects like cramping or diarrhea
Appetite effects typically emerge around weeks 3-4
Moradi M, Kousheh SA, Almasi H, Alizadeh A, Guimares JT, Ylmaz N, Lotfi A (2020) Postbiotics produced by lactic acid bacteria: the next frontier in food safety
Also, be patient